IN2015DN01407A - - Google Patents

Download PDF

Info

Publication number
IN2015DN01407A
IN2015DN01407A IN1407DEN2015A IN2015DN01407A IN 2015DN01407 A IN2015DN01407 A IN 2015DN01407A IN 1407DEN2015 A IN1407DEN2015 A IN 1407DEN2015A IN 2015DN01407 A IN2015DN01407 A IN 2015DN01407A
Authority
IN
India
Prior art keywords
body fluid
epithelial tumour
cells
spheroids
subpopulation
Prior art date
Application number
Other languages
English (en)
Inventor
Ulrich Pachmann
Katharina Pachmann
Original Assignee
Ulrich Pachmann
Katharina Pachmann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ulrich Pachmann, Katharina Pachmann filed Critical Ulrich Pachmann
Publication of IN2015DN01407A publication Critical patent/IN2015DN01407A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • C12N5/0694Cells of blood, e.g. leukemia cells, myeloma cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • C12N5/0695Stem cells; Progenitor cells; Precursor cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/02Atmosphere, e.g. low oxygen conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10Growth factors
    • C12N2501/11Epidermal growth factor [EGF]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00Culture process characterised by temperature
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0062General methods for three-dimensional culture
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00Labels used in chemical analysis of biological material
    • G01N2458/30Electrochemically active labels

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IN1407DEN2015 2012-08-03 2013-08-02 IN2015DN01407A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102012213838.2A DE102012213838A1 (de) 2012-08-03 2012-08-03 Verfahren zur Kultivierung einer Subpopulation zirkulierender epithelialer Tumorzellen aus einer Körperflüssigkeit
PCT/EP2013/066325 WO2014020169A1 (de) 2012-08-03 2013-08-02 Verfahren zur kultivierung einer subpopulation zirkulierender epithelialer tumorzellen aus einer körperflüssigkeit

Publications (1)

Publication Number Publication Date
IN2015DN01407A true IN2015DN01407A (enExample) 2015-07-03

Family

ID=48916061

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1407DEN2015 IN2015DN01407A (enExample) 2012-08-03 2013-08-02

Country Status (15)

Country Link
US (2) US11015172B2 (enExample)
EP (2) EP3330373A1 (enExample)
CN (1) CN104685051A (enExample)
AU (1) AU2013298450B2 (enExample)
DE (1) DE102012213838A1 (enExample)
DK (1) DK2880152T3 (enExample)
ES (1) ES2673874T3 (enExample)
HR (1) HRP20180905T1 (enExample)
HU (1) HUE037771T2 (enExample)
IN (1) IN2015DN01407A (enExample)
PL (1) PL2880152T3 (enExample)
PT (1) PT2880152T (enExample)
SI (1) SI2880152T1 (enExample)
TR (1) TR201808441T4 (enExample)
WO (1) WO2014020169A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201707902PA (en) 2014-03-31 2017-11-29 Fisher & Paykel Healthcare Ltd Headgear for respiratory interfaces
EP3128325B1 (de) 2015-08-07 2019-01-02 Ulrich Pachmann Verfahren zur bestimmung einer konzentration epithelialer zellen in einer blutprobe oder aspiratsprobe
CN109196112B (zh) * 2016-06-16 2022-10-04 株式会社日立高新技术 球状体内部细胞状态的分析方法
CN108277255A (zh) * 2018-01-30 2018-07-13 陈晓凤 一种体外活性上皮肿瘤细胞的检测方法
JP6935883B2 (ja) * 2018-07-13 2021-09-15 五稜化薬株式会社 蛍光画像診断の前処理方法
KR102837377B1 (ko) * 2020-12-31 2025-07-23 아카데미아 시니카 세포 배양 시스템, 이의 제조방법 및 용도
US11713441B2 (en) 2020-12-31 2023-08-01 Academia Sinica Cell culture substrates, methods and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5734998A (en) * 1997-01-10 1998-08-03 Life Technologies, Inc. Embryonic stem cell serum replacement
CN1446583A (zh) * 2002-11-29 2003-10-08 帕弗瑞生物技术(北京)有限公司 一种肿瘤免疫治疗及预防性疫苗的组成、制备、应用方案
EP1664340A1 (en) * 2003-08-08 2006-06-07 Canbas Co., Ltd. Sensitivity test to predict efficacy of anti-cancer therapies
CA2447400A1 (en) * 2003-09-12 2005-03-12 The Hospital For Sick Children Brain tumor stem cells
CN102746336B (zh) * 2005-06-29 2015-08-19 施瑞修德制药公司 氨基磷酸酯烷化剂前体药物
US20070123448A1 (en) * 2005-11-23 2007-05-31 The Hospital For Sick Children Novel chemical entities affecting neuroblastoma tumor-initiating cells
GB2442059A (en) * 2006-09-19 2008-03-26 Ist Superiore Sanita Test for cancer of the gastrointestinal tract
FI20075417A0 (fi) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Koostumuksia ja menetelmiä alkion kantasolujen kasvatukseen
EP2138571B1 (en) * 2008-06-26 2017-04-12 SpheroTec GmbH Process for the preparation of multicellular spheroids
US20110081664A1 (en) * 2008-10-17 2011-04-07 University Of Massachusetts Multipurpose microfluidic device for mimicking a microenvironment within a tumor
EP2337561A4 (en) * 2008-10-23 2012-04-04 Davos Life Science Pte Ltd USE OF A TOCOTRIENOL COMPOSITION FOR THE PREVENTION OF CANCER
CN102021138B (zh) * 2009-09-15 2012-12-26 中国人民解放军第三军医大学第二附属医院 肿瘤干细胞的分离方法
DE102009047146B4 (de) * 2009-11-25 2012-07-19 Ulrich Pachmann Verfahren zum Vorhersagen des Ansprechens einer Tumorerkrankung auf eine therapeutische Maßnahme
US9439941B2 (en) * 2009-12-14 2016-09-13 The University Of Hong Kong Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells
US20110206735A1 (en) * 2010-02-24 2011-08-25 Yong Qian Tumorigenic CancerStemCells, Methods of Isolating and Using the Same
US20130078667A1 (en) * 2011-09-22 2013-03-28 Oscar B. Goodman Methods for detecting and collecting circulating tumor cells
EP2785871A4 (en) * 2011-11-28 2015-08-26 Baylor College Medicine CTC BIOMARKET TEST FOR COMBATING BRAIN METETAS IN BREAST CANCER
JP6509745B2 (ja) * 2013-01-25 2019-05-08 エックスセル・バイオサイエンシズ・インコーポレイテッド 標的細胞の選択的富化のための方法、組成物、キット、及びシステム

Also Published As

Publication number Publication date
AU2013298450A1 (en) 2015-03-12
WO2014020169A1 (de) 2014-02-06
DK2880152T3 (en) 2018-06-25
HRP20180905T1 (hr) 2018-08-24
EP2880152B1 (de) 2018-03-14
HUE037771T2 (hu) 2018-09-28
US11015172B2 (en) 2021-05-25
PL2880152T3 (pl) 2018-10-31
TR201808441T4 (tr) 2018-07-23
CN104685051A (zh) 2015-06-03
EP3330373A1 (de) 2018-06-06
DE102012213838A1 (de) 2014-02-06
EP2880152A1 (de) 2015-06-10
PT2880152T (pt) 2018-06-20
US20150299663A1 (en) 2015-10-22
ES2673874T3 (es) 2018-06-26
SI2880152T1 (sl) 2018-09-28
US20210238554A1 (en) 2021-08-05
AU2013298450B2 (en) 2019-01-17
US11920163B2 (en) 2024-03-05

Similar Documents

Publication Publication Date Title
PH12015501477A1 (en) Suspension and clustering of human pluripotent cells for differentiation into pancreatic endocrine cells
IN2015DN01407A (enExample)
IL273719B (en) Improved cell culture methods for stress cell therapy
MX2016005658A (es) Suspensión y agrupamiento de células madre humanas pluripotentes para la diferenciación a células endocrinas pancreáticas.
MY171710A (en) Culture medium composition, and method for culturing cell or tissue using said composition
GB2555728A (en) Cancer cell enrichment system
TR201904270T4 (tr) Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller.
MY156588A (en) Systems using cell culture for production of isoprene
IN2015KN00666A (enExample)
SG10201509930RA (en) Improved methods of cell culture for adoptive cell therapy
AU2011327239A8 (en) Stem cell suspension
GB201105226D0 (en) Methods
EP4527921A3 (en) Renal cell populations and uses thereof
HK1220404A1 (zh) 用於细胞培养的细胞外基质组合物珠粒
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
SG11201707858TA (en) Human serum albumin-containing culture medium for growth of neural stem cells
SG10201806083RA (en) Microcarrier perfusion culturing methods and uses thereof
EP2909303A4 (en) Bioreactor system and methods for alternative cell culture between static and dynamic
IL243634A0 (en) Method and medium for in vitro growth of stem cells
SG11201507828VA (en) Method for culturing hepatoblast-like cells and culture product thereof
EP2917337A4 (en) MEDIA FOR CULTIVATING, PRESERVING AND ADMINISTERING REGENERATIVE CELLS
SG11201503633VA (en) Methods of culturing cells or tissues and devices for cell or tissue culture
PL3652292T3 (pl) Naczynie do hodowli komórkowej 3d i sposoby hodowli komórkowej 3d
MX2015010887A (es) Formulaciones y metodos para aumentar la produccion de proteinas recombinantes.
MX2014012407A (es) Metodo para incrementar la secrecion de proteinas recombinantes.